CYBERDYNE Online Store



2024-01-24 updated

【News】MedicalNote, Inc., one of Japan’s most prominent medical information media for patients, and CYBERDYNE form a strategic partnership to provide information on progressive neuromuscular diseases

MedicalNote Inc. (Minato-ku, Tokyo; Representative Director and CEO: Yuma Umeda; Representative Director: Sho Inoue;) has entered into a strategic partnership with CYBERDYNE Inc. (Tsukuba, Ibaraki; President and CEO: Yoshiyuki Sankai; from now on “CYBERDYNE”). The strategic partnership aims to help the patient select appropriate treatment methods by posting information on various diseases, such as progressive neuromuscular diseases.

Background of the strategic partnership

Progressive Neuro Muscular Diseases such as Spinal Muscular Atrophy (SMA), Spinal and Bulbar Muscular Atrophy (SBMA), Amyotrophic Lateral Sclerosis (ALS), Charcot-Marie-Tooth disease (CMT), Distal Myopathy, Inclusion Body Myositis (IBM), Congenital Myopathy, and Muscular Dystrophy are known to be diseases that are very difficult to cure, and an important issue is how to suppress the worsening of muscle weakness and atrophy of skeletal muscle. To approach this challenge, CYBERDYNE developed Medical HAL Lower Limb Type (generic name: biosignal-responsive motor function improvement device, hereafter referred to as “Medical HAL”). Medical HAL is already covered by insurance for these progressive neuromuscular diseases and is also used in clinical settings. In October 2023, treatment of Medical HAL has expanded to two new diseases, HTLV-1 associated myelopathy (“HAM”) and hereditary spastic paraplegia. When the Guide for Appropriate Use revision is completed, hospitals can seek reimbursement whenever HAL is used to treat such diseases.

Medical HAL is a unique system that utilizes a faint bio-electrical signal that leaks on the skin surface when a person tries to move their body. The sensor of Medical HAL reads information that reflects the person’s intention to move that is sent from the brain to the muscles. By repeating walking exercises while supporting the wearer’s movements according to the wearer’s intention, the walking function of the patient could be improved. Further effect is also hoped for through combination with pharmaceuticals.

Despite the potential of this new treatment method to control the progression of neuromuscular diseases, some patients are not benefiting from them because of a lack of information that reaches them.


With a vision to realize a society where everyone can choose the most appropriate medical treatment without hesitation, MedicalNote Inc. has focused on raising awareness of intractable and rare diseases since its inception. “Medical Note,” a medical information media for general consumers and patients, is linked to Yahoo! Search and Google Search, and the media has one of the largest user bases in Japan. Furthermore, by collaborating with various companies, MedicalNote Inc. provides reliable medical information based on the latest evidence and clinical experience of experts on intractable and rare diseases.

MedicalNote and CYBERDYNE will jointly strengthen the provision of disease information for patients regarding progressive neuromuscular disease in both quality and quantity. By providing up-to-date and reliable information based on interviews with doctors specializing in this disease,  MedicalNote and CYBERDYNE aim to realize a society where more patients with progressive neuromuscular diseases can receive appropriate treatment.

About MedicalNote Inc.

MedicalNote Inc. is a company with the vision of “connecting doctors and patients” and aims to create a society in which everyone can confidently select the right medical option that is suited for them. The company operates “Medical Note”, a medical information media for the general public and patients. With the cooperation of doctors and specialists who continue to be active on the front lines of clinical practice, research, and education, the media aims to deliver reliable medical information based on the latest evidence and specialists’ clinical experience to many people. MedicalNote Inc. has strengths not only in general diseases but also in diseases with significant challenges, such as cancer, especially in the areas of intractable and rare diseases. By integrating the real and digital worlds, MedicalNote Inc. aims to make medical care more accessible and realize a society where everyone can choose the most appropriate medical care.

【Introduction to services by MedicalNote Inc.】

With the cooperation of approximately 3,100 doctors, “Medical Note” is one of the largest media platforms in Japan, providing reliable medical information on diseases and symptoms to the general public. The medical information is also linked to Yahoo! Search and Google Search.

【Business Outline】
Company name: MedicalNote Inc.
Adress:5F Stadium Place Aoyama, 2-9-5 Kita-Aoyama, Minato-ku, 107-0061, Tokyo, Japan
Established: October 2014
Representative Director and CEO:Yuma Umeda
Representative Director: Sho Inoue
Business outline: Digital innovation business, healthcare business, platform business
Corporate site
For contacts regarding the press


Established in June 2004 as a venture company originated from Tsukuba University. Using the new field of “Cybernics,” which combines human, robotics, and information systems, the company focuses on promoting business to create the future as it should be by researching, developing, manufacturing, and shipping innovative Cybernics systems, mainly for medical, welfare, lifestyle, and workplace applications. The world’s first medical Wearable Cyborg, “Medical HAL,” has been deployed worldwide.